Ultimovacs ASA (ULTI.OL)

NOK 2.05

(0.0%)

Gross Profit Summary of Ultimovacs ASA

  • Ultimovacs ASA's latest annual gross profit in 2023 was -2.76 Million NOK , down -4.53% from previous year.
  • Ultimovacs ASA's latest quarterly gross profit in 2024 Q2 was -713 Thousand NOK , up 0.28% from previous quarter.
  • Ultimovacs ASA reported a annual gross profit of -2.64 Million NOK in annual gross profit 2022, up 2.03% from previous year.
  • Ultimovacs ASA reported a annual gross profit of -2.7 Million NOK in annual gross profit 2021, up 0.63% from previous year.
  • Ultimovacs ASA reported a quarterly gross profit of -713 Thousand NOK for 2024 Q2, up 0.28% from previous quarter.
  • Ultimovacs ASA reported a quarterly gross profit of -699 Thousand NOK for 2023 Q1, down -0.72% from previous quarter.

Annual Gross Profit Chart of Ultimovacs ASA (2023 - 2016)

Historical Annual Gross Profit of Ultimovacs ASA (2023 - 2016)

Year Gross Profit Gross Profit Growth
2023 -2.76 Million NOK -4.53%
2022 -2.64 Million NOK 2.03%
2021 -2.7 Million NOK 0.63%
2020 -2.72 Million NOK -31.85%
2019 -2.06 Million NOK -243.26%
2018 -601 Thousand NOK -12.55%
2017 -534 Thousand NOK -9.2%
2016 -489 Thousand NOK 0.0%

Peer Gross Profit Comparison of Ultimovacs ASA

Name Gross Profit Gross Profit Difference
Arctic Bioscience AS 9.77 Million NOK 128.321%
Aqua Bio Technology ASA 607.92 Thousand NOK 555.318%
ArcticZymes Technologies ASA 113.01 Million NOK 102.449%
BerGenBio ASA 354 Thousand NOK 881.921%
Hofseth BioCare ASA 29.87 Million NOK 109.265%
PCI Biotech Holding ASA 2.99 Million NOK 192.575%
Thor Medical ASA - NOK Infinity%